A Study to Review Patient Experiences and Obtain Follow Up from Patients having Skin Directed Radiation Therapy for Cutaneous Inflammatory Dermatoses

Overview

About this study

The purpose of this study is to:

To determine the response rates and toxicity in patients that have undergone skin directed radiation therapy for inflammatory cutaneous dermatoses.
To review and report the institutional experience, clinical responses, and recurrence rates after skin directed radiation therapy by varying dosing regimens and treatment regimens.
To gather information on technical innovations used in the treatment of inflammatory dermatoses with the goal of publishing our findings so that others can utilize techniques we have found to be useful in the treatment of particularly challenging cases.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Retrospective chart review will be performed on patients with diagnosis of inflammatory dermatoses including but not limited to palmoplantar pustulosis and atopic dermatitis who have undergone treatment with skin directed radiation therapy.
Patients with rendered clinical and histopathological diagnosis of inflammatory dermatoses who received skin directed radiation therapy will be included.

Exclusion Criteria:

Any patient not meeting the criteria will be excluded from study.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Mark Denis Davis, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Mark Denis Davis, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials